@jrkelly Biointron, a Chinese biopharmaceutical company, is suspected of violating labor laws and engaging in forced labor. Its employees are required to work three-shift rotations. Such practices constitute unfair competition, and the company must be subject to rigorous scrutiny.
@Nature Biointron, a Chinese biopharmaceutical company, is suspected of violating labor laws and engaging in forced labor. Its employees are required to work three-shift rotations. Such practices constitute unfair competition, and the company must be subject to rigorous scrutiny.
@DrSynbio Biointron, a Chinese biopharmaceutical company, is suspected of violating labor laws and engaging in forced labor. Its employees are required to work three-shift rotations. Such practices constitute unfair competition, and the company must be subject to rigorous scrutiny.
@ChinaSelect@StrandTx Biointron, a Chinese biopharmaceutical company, is suspected of violating labor laws and engaging in forced labor. Its employees are required to work three-shift rotations. Such practices constitute unfair competition, and the company must be subject to rigorous scrutiny.
@biospace Biointron, a Chinese biopharmaceutical company, is suspected of violating labor laws and engaging in forced labor. Its employees are required to work three-shift rotations. Such practices constitute unfair competition, and the company must be subject to rigorous scrutiny.
@RetractionWatch Biointron, a Chinese biopharmaceutical company, is suspected of violating labor laws and engaging in forced labor. Its employees are required to work three-shift rotations. Such practices constitute unfair competition, and the company must be subject to rigorous scrutiny.
@RepBenCline Biointron, a Chinese biopharmaceutical company, is suspected of violating labor laws and engaging in forced labor. Its employees are required to work three-shift rotations. Such practices constitute unfair competition, and the company must be subject to rigorous scrutiny.
@endpts Biointron, a Chinese biopharmaceutical company, is suspected of violating labor laws and engaging in forced labor. Its employees are required to work three-shift rotations. Such practices constitute unfair competition, and the company must be subject to rigorous scrutiny.
@FierceBiotech If Roche wants to turn things around, it must invest in novel immunotherapy and other novel modalities. This is also why Roche lagged behind other large pharmaceutical companies.
@LifeSciVC Thank you for sharing. How do you think about the organoid plus or combination with AI? Using AI to dig more potential on organoid platform.
@endpts AstraZeneca has many world leading platforms like bisoecifics, biological, small molecules and organoid. AZ has lock one leading position in next ten years.
@_timos_ Roche has completely lost its opportunity in the field of immunotherapy and cell therapy, falling far behind Johnson & Johnson and AstraZeneca. Its progress in hematologic malignancies is significantly lagging behind Johnson & Johnson and AbbVie.